| JPMORGAN ETFS (IRELAND) ICAV - USD CORPORATE BOND RESEARCH ENHANCED INDEX (ESG) UCITS ETF EUR H (A) | DEUDA PRIVADA USA | 4,16% | 5,78% | · | · |
| JPMORGAN ETFS (IRELAND) ICAV - USD CORPORATE BOND RESEARCH ENHANCED INDEX (ESG) UCITS ETF USD (DIS) | DEUDA PRIVADA USA | -7,24% | -10,97% | · | · |
| JPM PACIFIC EQUITY I2 (ACC) USD | RVI ASIA | 3,87% | 14,18% | · | · |
| JPM PACIFIC EQUITY I (DIST) EUR | RVI ASIA | 2,53% | 11,15% | · | · |
| JPM SGD LIQUIDITY LVNAV E (ACC) | MONETARIO INTERNACIONAL - OTROS | 0,21% | · | · | · |
| JPM SGD LIQUIDITY LVNAV E (DIST) | MONETARIO INTERNACIONAL - OTROS | -2,71% | · | · | · |
| JPM THEMATICS-GENETIC THERAPIES C (DIST) USD | BIOTECNOLOGÍA | -22,21% | -30,02% | · | · |
| JPM THEMATICS-GENETIC THERAPIES D (ACC) USD | BIOTECNOLOGÍA | -23,18% | -32,73% | · | · |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | BIOTECNOLOGÍA | -21,95% | -29,45% | · | · |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | BIOTECNOLOGÍA | -22,26% | -29,66% | · | · |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | -17,28% | -26,18% | · | · |
| JPM US AGGREGATE BOND I2 (DIST) CHF (HEDGED) | RFI USA | -0,53% | -6,28% | · | · |
| JPM US AGGREGATE BOND I (ACC) EUR | RFI USA | -4,06% | -2,87% | · | · |
| JPM US AGGREGATE BOND I (DIST) USD | RFI USA | -5,34% | · | · | · |
| JPM USD LIQUIDITY LVNAV D (ACC) | MONETARIO USA | -4,55% | · | · | · |
| JPM USD TREASURY CNAV A (ACC) | MONETARIO USA | -4,64% | · | · | · |
| JPM USD TREASURY CNAV CAPITAL (ACC) | MONETARIO USA | -4,34% | 2,79% | · | · |
| JPM USD TREASURY CNAV D (ACC) | MONETARIO USA | -4,70% | · | · | · |
| JPM USD TREASURY CNAV INSTITUTIONAL (ACC) | MONETARIO USA | -4,39% | · | · | · |
| JPM US SELECT EQUITY I2 (DIST) USD | RVI USA | 0,16% | · | · | · |
